Avant Diagnostics, Inc. (OTC:AVDX)

Avant Diagnostics, Inc., a commercial-stage molecular data-generating company, focuses on the development and commercialization of proprietary data-generating assays that provide information for physicians and patients in the areas of cancers. It owns license and distribution right for OvaDx, a noninvasive proteomics diagnostic screening test for the early detection of ovarian cancer. The company was founded in 2009 and is based in Washington, District of Columbia.

Current Quote*
Last: $0.009
Change: 0.000
Book: $0.400
Volume: 4,178

As Of: 04/16 13:31 ET
*Quotes delayed by 20min.

BuyIns.Net Alerts for Symbol AVDX

  • No BuyIns.Net Alerts Available for AVDX

Graphs for AVDX


3 Month Graph


6 Month Graph


1 Year Graph